GO
Loading...

Latest Video

Citizens Financial's IPO has been priced at $21.50 per share, making it the second biggest in the U.S. this year after Alibaba. Marty Mosby, Director of Bank & Equity Strategies at Vining Sparks, discusses.

Fonterra: Dairy sector will rebound     Tue, 23 Sep '14 | 8:06 PM ET

Theo Spierings, CEO of Fonterra, explains why he thinks global dairy prices will return to normal by March 2015.

Esprit CEO: Restructuring has paid off     Tue, 23 Sep '14 | 6:45 PM ET

Jose Manuel Martínez Gutiérrez, Executive Director & Group CEO of Esprit, says restructuring plans have stabilized the firm and discusses the brand's next move.

Christopher Field, Co-Chair of Working Group II, IPCC, discusses the challenges in galvanizing global efforts to halt the problem of climate change.

Two stocks you can buy now     Tue, 23 Sep '14 | 7:00 PM ET

One tech, one pharmaceutical -- each too good to ignore.

Alibaba's successful initial public offering has put China's technology space in the spotlight. Bruno Del Ama, CEO at Global X Funds, describes the outlook and opportunities in the sector.

Gaurav Sodhi, Resources Analyst at Intelligent Investor, discusses why major producers like Vale are cranking up iron ore output despite the recent slump in prices.

Mad Money host Jim Cramer explains what's plaguing money transfer companies like Western Union and Xoom Corporation.

Peter Boockvar, Chief Market Analyst at The Lindsey Group, says U.S. stocks have been too nonchalent about the end of the Fed's quantitative easing.

Cramer: Pain now, gains later     Tue, 23 Sep '14 | 6:00 PM ET

Mad Money host Jim Cramer dissects the biggest red flags for investors right now, and what the Treasury's newest tax inversion rules mean for your money.

Off the Charts: Nat gas bouncing back?     Tue, 23 Sep '14 | 6:15 PM ET

Natural gas is down nearly 10 percent so far this year. Mad Money host Jim Cramer goes off the charts with the help of technician Carley Garner's take on nat gas' next direction.

Race to treat ebola     Tue, 23 Sep '14 | 5:47 PM ET

The FDA authorized Tekmira's ebola drug for potential use through an expanded access program. CNBC's Meg Tirrell reports which other companies are working on drugs to fight ebola.

Options Action: Bullish bet on DG     Tue, 23 Sep '14 | 5:45 PM ET

A look at the bullish bet on Dollar General in the options market, with "Fast Money" trader Dan Nathan.

Stock Pops & Drops: BTU, FB & more     Tue, 23 Sep '14 | 5:40 PM ET

The Fast Money traders take a look at today's biggest market movers.

Apple scales back on GT     Tue, 23 Sep '14 | 5:36 PM ET

Shares of GT Advanced Technologies are soaring despite Apple's decision not to include its scratch-resistant sapphire screens in the iPhone 6. Pavel Molchanov, Raymond James, provides perspective.

iPhone 6 component plays     Tue, 23 Sep '14 | 5:32 PM ET

The "Fast Money" traders dissect the iPhone component companies and how they're trading, including InvenSense, Qualcomm and NXP Semiconductor.

Rumor Patrol: 3D Systems & Gogo     Tue, 23 Sep '14 | 5:25 PM ET

Two stocks seeing big moves higher on a slew of rumors hitting Wall Street, with the "Fast Money" traders.

Losing day: Market bright spots     Tue, 23 Sep '14 | 5:01 PM ET

After another day of losses for stocks, the "Fast Money" traders discuss whether the markets saw a top on Friday when Alibaba went public, and their biggest market concerns right now.

Dissecting what caused the move to the downside in today's market close, with Shark Tank investor Kevin O'Leary; CNBC's Kate Kelly; Kenny Polcari, O'Neil Securities; and CNBC contributor Carol Roth.

Pricing risk & market complacency     Tue, 23 Sep '14 | 2:03 PM ET

Discussing geopolitics and if the U.S. stock market is correctly pricing risk, with Larry McDonald, Newedge USA, and John Hailer, Natixis Global Asset Management.

Top Trades: BBRY & AGN     Tue, 23 Sep '14 | 5:17 PM ET

In Tuesday's "Top Trades," the "Fast Money" traders explain their view of the downgrade for BlackBerry, as well as reports Allergan is in talks to buy Salix Pharmaceuticals.

Bed, Bath & Beyond's earnings beat     Tue, 23 Sep '14 | 5:16 PM ET

CNBC's Kate Rogers reports on the Q2 earnings beat from Bed, Bath & Beyond.

New tax rules from Treasury     Tue, 23 Sep '14 | 5:07 PM ET

The Treasury has made it more difficult for U.S. companies to decide to move their headquarters outside of the U.S. Edward Mills, FBR Capital Markets, discusses what kind of legislation, if any, could come from Congress on inversions.

Former President Bill Clinton predicted U.S. corporations will care more about employees and customers rather than shareholders in the future. The "Closing Bell" panel weighs in.

Direct scotch exports to China are down 39 percent from last year. John Rutledge, Safanad, and the "Closing Bell" panel, discuss the decline in consumption.

Obama meets with Arab leaders     Tue, 23 Sep '14 | 4:43 PM ET

CNBC's Eamon Javers reports President Obama is meeting with Arab leaders in New York City for help in the fight against ISIS.

Did Apple make a huge mistake with the iPhone 6 Plus? Lance Ulanoff, Mashable; Larry Fishelson, Dynalink; and the "Closing Bell" panel, share their opinions.

The director of the next Batman movie posts photos of the Batmobile, which looks more like a tank. Ryan Friendlinghaus of West Coast Customs estimates a working model would cost as much as $9 million.

CNBC.com managing editor Allen Wastler shares which stories are heating up on the web, including former President Bill Clinton's comments at the Clinton Global Initiative, as well as a story on the real problem with millennials.

Stock picks in the selloff     Tue, 23 Sep '14 | 4:25 PM ET

Discussing the action in small cap stocks, and opportunities amid the selloff, Joel Greenblatt, Gotham Funds founder.

Contact Latest Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Video and TV

U.S. Video

Asia Video

Europe Video